Royce & Associates LP AMAG PHARMACEUTICALS INC Transaction History

Royce & Associates LP

  • $10.3 Billion
  • Q4 2024

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 12, 2020
SELL
N/A
-7,412 Closed
0 $0
Q2 2020

Aug 07, 2020
SELL
N/A
-9,524 Reduced 56.24%
7,412 $57,000
Q1 2020

May 12, 2020
SELL
N/A
-179,736 Reduced 91.39%
16,936 $105,000
Q4 2019

Feb 06, 2020
SELL
N/A
-99,126 Reduced 33.51%
196,672 $2.39 Million
Q3 2019

Nov 13, 2019
SELL
N/A
-263,509 Reduced 47.11%
295,798 $3.42 Million
Q2 2019

Aug 12, 2019
SELL
N/A
-155,150 Reduced 21.72%
559,307 $5.59 Million
Q1 2019

May 09, 2019
BUY
N/A
47,553 Added 7.13%
714,457 $9.2 Million
Q4 2018

Feb 11, 2019
BUY
N/A
582,135 Added 686.73%
666,904 $10.1 Million
Q3 2018

Nov 13, 2018
BUY
N/A
83,890 Added 9543.8%
84,769 $1.7 Million
Q2 2018

Aug 09, 2018
BUY
N/A
266 Added 43.39%
879 $17,000
Q1 2018

May 14, 2018
SELL
N/A
-246 Reduced 28.64%
613 $12,000
Q4 2017

Feb 09, 2018
BUY
N/A
284 Added 49.39%
859 $11,000
Q3 2017

Nov 13, 2017
BUY
N/A
575
575 $11,000
Track This Portfolio

Track Royce & Associates LP Portfolio

Follow Royce & Associates LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royce & Associates LP, based on Form 13F filings with the SEC.

News

Stay updated on Royce & Associates LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email